XML 56 R40.htm IDEA: XBRL DOCUMENT v3.25.4

Investment in NuScale (Tables)

12 Months Ended

Dec. 31, 2025

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments

The components of equity method earnings are as follows:

			Year Ended December 31,
(in millions)			2025						2024
Equity method earnings
Gain (loss) on the fair value of our investment in NuScale			$	(419)					$	2,221
Gain on the fair value of the forward sale contract of NuScale shares			208						—
Gain on the sale of NuScale shares			336						—
Other			85						(116)
Equity method earnings			$	210					$	2,105

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

+ Details

Name:	us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration